InvestorsHub Logo
Followers 6
Posts 1400
Boards Moderated 0
Alias Born 08/24/2014

Re: None

Wednesday, 04/25/2018 12:03:50 PM

Wednesday, April 25, 2018 12:03:50 PM

Post# of 48316
Oncosec will be presenting preliminary PISCES data at upcoming ASCO conference:

Abstract TPS9601
Trial in progress: A phase 2 study of intratumor pil-12 plus electroporation in combination with intravenous pembrolizumab in patients with stage III/IV mealanoma progressing on either pembrolizumab or nivolumab treatment (PISCES).

Robert Hans Ingemar Andtbacka, MD - First Author
Huntsman Cancer Institute at the University of Utah

https://iplanner.asco.org/am2018/#/
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ONCSQ News